EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colo‐Protective Effects of Pentoxifylline Alone or in Combination With Mesalamine in Colitis Through Sphingosine Kinase 1/Sphingosine 1 Phosphate, and Zonula Occuldin 1 Pathways: New Molecular Approach

Fatemah A Alherz, Mahmoud S Abdallah, Esraa M Mosalam, Mostafa M Bahaa iD, Thanaa A Elmasry, Mohamad A El-Gammal, Walaa A Negm, AyaIbrahim Elberri, Nora Elshorbagi, Hend E Abo Mansour, Amir O Hamouda, Muhammed M Salahuddin und 7 weitere

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Fatemah A Alherz und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Pentoxifylline, Colitis, Ulcerative, Mesalamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple signaling pathways have been implicated in the pathogenesis of ulcerative colitis (UC), including Sphingosine Kinase 1 (SPHK)/Sphingosine‐1‐Phosphate (S1P), AMP‐activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR)/NLR family pyrin domain‐containing 3 (NLRP3), zonula occludens‐1 (ZO‐1), and signal transducer and activator of transcription 3 (STAT3). We aimed to investigate the Colo protective and anti‐ulcerative effects of pentoxifylline (PTX) in a rat model of UC. Colitis was induced by intracolonic administration of 2 mL of 3% (v/v) acetic acid (AA). Thirty‐five rats were randomly assigned to five groups ( n = 7 each): normal control, colitis, mesalamine, PTX, and a combination of PTX plus mesalamine. Disease activity was assessed using the disease activity index, colon weight and length measurements, histological examination, and immunohistochemical detection of caspase‐3. Colonic tissue homogenates were analyzed for interleukin‐6 (IL‐6), S1P, SPHK, mTOR, heme oxygenase‐1 (HO‐1), nuclear factor erythroid 2–related factor 2 (Nrf2), AMPK, and STAT3 levels. Gene expression of ZO‐1 and NLRP3 was also evaluated. Intracolonic AA induced marked functional, biochemical, and inflammatory damage to colonic tissue. Treatment with PTX, mesalamine, or their combination significantly attenuated these effects. Specifically, all treatments reduced levels of IL‐6, S1P, SPHK, mTOR, STAT3, NLRP3, and caspase‐3, while increasing levels of ZO‐1, HO‐1, Nrf2, and AMPK. The combination treatment group exhibited near‐complete restoration of normal colonic architecture, characterized by intact crypt morphology and minimal fibrosis in the lamina propria. PTX attenuated inflammation, apoptosis, and oxidative stress in colitis, supporting its potential as an adjuvant therapy in UC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PentoxifyllineColitis, UlcerativeMesalamineAnimalsPhosphotransferases (Alcohol Group Acceptor)MaleRatsLysophospholipidsSphingosineSignal TransductionZonula Occludens-1 ProteinDisease Models, AnimalDrug Therapy, CombinationColonSTAT3 Transcription FactorTOR Serine-Threonine KinasesApoptosisRats, WistarNLR Family, Pyrin Domain-Containing 3 ProteinOxidative StressAMP-Activated Protein KinasesHeme Oxygenase (Decyclizing)Sphingosine Kinase

Stichwörter der Autor:innen

IL6/STAT3Nrf2/HO‐1PTXSPHK/S1PZO‐1ulcerative colitis

Substanzen

PentoxifyllinePhosphotransferases (Alcohol Group Acceptor)LysophospholipidsSphingosineMesalamineZonula Occludens-1 ProteinSTAT3 Transcription FactorTOR Serine-Threonine KinasesNLR Family, Pyrin Domain-Containing 3 ProteinAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Department of PharmD, Faculty of Pharmacy, Jadara University, Irbid, Jordan.
  • Biochemistry Department, Faculty of Pharmacy, Menoufia University, Shebin EL-Kom, Menoufia, Egypt.
  • Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt.
  • Pharmacologyand Toxicology Department, Faculty of Pharmacy, Sinai University, Arish Branch, Arish, Egypt.

ORCID-Profile: Mostafa M Bahaa

Zitieren

APA

Alherz, F. A., Abdallah, M. S., Mosalam, E. M., Bahaa, M. M., Elmasry, T. A., El-Gammal, M. A., Negm, W. A., Elberri, A., Elshorbagi, N., Abo Mansour, H. E., Hamouda, A. O., Salahuddin, M. M., Yasser, M., Eldesoqui, M., Alrubia, S., Alsegiani, A. S., El-Khateeb, E., ElMahdy, M. K., & Wahsh, E. (2025). Colo‐Protective Effects of Pentoxifylline Alone or in Combination With Mesalamine in Colitis Through Sphingosine Kinase 1/Sphingosine 1 Phosphate, and Zonula Occuldin 1 Pathways: New Molecular Approach. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70115

Vancouver

Alherz FA, Abdallah MS, Mosalam EM, Bahaa MM, Elmasry TA, El-Gammal MA, et al. Colo‐Protective Effects of Pentoxifylline Alone or in Combination With Mesalamine in Colitis Through Sphingosine Kinase 1/Sphingosine 1 Phosphate, and Zonula Occuldin 1 Pathways: New Molecular Approach. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70115

BibTeX
@article{Alherz2025,
  author = {Alherz, Fatemah A and Abdallah, Mahmoud S and Mosalam, Esraa M and Bahaa, Mostafa M and Elmasry, Thanaa A and El-Gammal, Mohamad A and Negm, Walaa A and Elberri, AyaIbrahim and Elshorbagi, Nora and Abo Mansour, Hend E and Hamouda, Amir O and Salahuddin, Muhammed M and Yasser, Mohamed and Eldesoqui, Mamdouh and Alrubia, Sarah and Alsegiani, Amsha S and El-Khateeb, Eman and ElMahdy, Mohamed Kh and Wahsh, Eman},
  title = {Colo‐Protective Effects of Pentoxifylline Alone or in Combination With Mesalamine in Colitis Through Sphingosine Kinase 1/Sphingosine 1 Phosphate, and Zonula Occuldin 1 Pathways: New Molecular Approach},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70115}
}
Kostenlos starten →